[1]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
https://doi.org/10.3322/caac.21660
|
[2]
|
Akinyemiju, T., Abera, S., Ahmed, M., et al. (2017) The Burden of Pri-mary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015. JAMA Oncology, 3, 1683-1691.
|
[3]
|
Estes, C., Razavi, H., Loomba, R., et al. (2018) Modeling the Epidemic of Nonalcoholic Fatty Liver Disease Demonstrates an Exponential Increase in Burden of Disease. Hepatology, 67, 123-133. https://doi.org/10.1002/hep.29466
|
[4]
|
Cabibbo, G., Enea, M., Atta-nasio, M., et al. (2010) A Meta-Analysis of Survival Rates of Untreated Patients in Randomized Clinical Trials of Hepa-tocellular Carcinoma. Hepatology, 51, 1274-1283. https://doi.org/10.1002/hep.23485
|
[5]
|
Zhang, Z.M., Lai, E.C., Zhang, C., et al. (2015) The Strategies for Treating Primary Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. International Journal of Surgery, 20, 8-16. https://doi.org/10.1016/j.ijsu.2015.05.009
|
[6]
|
Zhang, Z., Lai, E.C., Zhang, C., et al. (2015) The Strategies for Treating Primary Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. International Journal of Surgery, 20, 8-16. https://doi.org/10.1016/j.ijsu.2015.05.009
|
[7]
|
Ikai, I., Yamamoto, Y., Yamamoto, N., Terajima, H., et al. (2003) Results of Hepatic Resection for Hepatocellular Carcinoma Invading Major Portal and/or Hepatic Veins. Surgical Oncology Clinics of North America, 12, 65-75.
https://doi.org/10.1016/S1055-3207(02)00082-0
|
[8]
|
Cheng, S.Q., et al. (2007) Tumor Thrombus Types Influence the Prognosis of Hepatocellular Carcinoma with the Tumor Thrombi in the Portal Vein. Hepatogastroenterology, 54, 499-502.
|
[9]
|
Chung, G.E., Lee, J.H., Kim, H.Y., et al. (2011) Transarterial Chemoembolization Can Be Safely Per-formed in Patients with Hepatocellular Carcinoma Invading the Main Portal Vein and May Improve the Overall Survival. Radiology, 258, 627-634. https://doi.org/10.1148/radiol.10101058
|
[10]
|
Luo, J., Guo, R.P., Lai, E.C., et al. (2011) Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Prospective Comparative Study. Annals of Surgical Oncology, 18, 413-420.
https://doi.org/10.1245/s10434-010-1321-8
|
[11]
|
Huo, Y.R. and Eslick, G.D. (2015) Transcatheter Arterial Che-moembolization plus Radiotherapy Compared with Chemoembolization Alone for Hepatocellular Carcinoma: A System-atic Review and Meta-Analysis. JAMA Oncology, 1, 756-765. https://doi.org/10.1001/jamaoncol.2015.2189
|
[12]
|
Li, M.F., Leung, H.W., Chan, A.L., et al. (2018) Network Meta-Analysis of Treatment Regimens for Inoperable Advanced Hepatocellular Carcinoma with Portal Vein Invasion. Therapeutics and Clinical Risk Management, 14, 1157-1168. https://doi.org/10.2147/TCRM.S162898
|
[13]
|
Liu, B.J., Gao, S., Zhu, X., et al. (2021) Combination Therapy of Chemoembolization and Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Compared with Chemoembolization Alone: A Propensity Score-Matched Analysis. BioMed Research In-ternational, 2021, Article ID: 6670367.
https://doi.org/10.1155/2021/6670367
|
[14]
|
Guo, L., Wei, X., Feng, S., et al. (2022) Radiotherapy Prior to or after Transcatheter Arterial Chemoembolization for the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Randomized Controlled Trial. Hepatology International, 16, 1368-1378. https://doi.org/10.1007/s12072-022-10423-7
|
[15]
|
Huang, M., Lin, Q., Wang, H., et al. (2016) Survival Benefit of Chemoembolization plus Iodine125 Seed Implantation in Unresectable Hepatitis B-Related Hepatocellular Carcinoma with PVTT: A Retrospective Matched Cohort Study. European Radiology, 26, 3428-3436. https://doi.org/10.1007/s00330-015-4198-x
|
[16]
|
Zhu, K., Chen, J., Lai, L., et al. (2014) Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Treatment with Transarterial Chemoembolization Combined with Sorafenib—A Ret-rospective Controlled Study. Radiology, 272, 284-293.
https://doi.org/10.1148/radiol.14131946
|
[17]
|
Ding, X., Sun, W., Li, W., et al. (2021) Transarterial Chemoemboli-zation plus Lenvatinib versus Transarterial Chemoembolization plus Sorafenib as First-Line Treatment for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Prospective Randomized Study. Cancer, 127, 3782-3793. https://doi.org/10.1002/cncr.33677
|
[18]
|
Fan, W., Yuan, G., Fan, H., et al. (2019) Apatinib Combined with Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma and Portal Vein Tumor Thrombus: A Multi-center Retrospective Study. Clinical Therapeutics, 41, 1463-1476. https://doi.org/10.1016/j.clinthera.2019.04.036
|